WST Stock Analysis: Buy, Sell, or Hold?
WST - West Pharmaceutical Services, Inc.
$245.92
2.57 (1.06%)
▲
5d:
+1.87%
30d:
-3.31%
90d:
-10.35%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 23, 2026
23d
Smart Money Distribution
WST is up 4.2% this week, but smart money is buying puts. Top strike: $210 2026-05-15 with 3,337 OI. Put ratio: 99% View Scanner →
Strength: 7.0/10
Get Alerted When WST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: WST trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: WST trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$313.01
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$194.35
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WST is currently trading at $245.92, which is considered fair relative to its 30-day fair value range of $238.14 to $249.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.5) compared to its historical average (31.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This pessimistic expectation contrasts with the company's recent 2.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, WST is in a strong downtrend. The price is approaching resistance at $252.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: WST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $316.69 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WST is in a strong downtrend. The price is approaching resistance at $252.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: WST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $316.69 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$238.14 -
$249.10
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.1% below Wall St target ($316.69)
Fair Price Analysis
30-Day Fair Range
$238.14 -
$249.10
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$13.82
(5.6%)
Support & Resistance Levels
Support Level
$234.58
Resistance Level
$252.41
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.49
Wall Street Target
$316.69
(+30.1%)
Revenue Growth (YoY)
7.5%
Earnings Growth (YoY)
2.1%
Profit Margin
16.1%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
27.5 vs 31.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$232.89
(-4%)
2-Year Target
$222.87
(-8%)
3-Year Target
$213.29
(-12%)
3-Yr Target (if PE normalizes)
(PE: 27→31)
$243.66
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.5, Growth: 10.4%)
$327.06
(+34%)
Base:
(SPY PE: 22.4, Growth: 10.4%)
$266.54
(+10%)
Bear:
(PE: 19.0, Growth: 10.4%)
$226.56
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 34.96 | Current EPS (TTM): $6.78
Bull Case
$340.12
(+41%)
Analyst growth 30.4%, PE expands to 38.5
Base Case
$309.20
(+28%)
Market implied 30.4%, PE stable at 35.0
Bear Case
$161.18
(-33%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.5 to 31.4
Stabilization Target:
$278.01
(+14.2%)
PE Expansion Potential:
+14.2%
Share & Embed Analysis
Last updated: March 30, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
Data refreshes hourly during market hours. Next update: 11:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WST showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
SELL
2026-02-05
Ro Khanna
BUY
2026-01-29
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 51 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 54 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 61 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 58 HOLD |
Advanced WST Option Strategies
Professional options setups generated by AI based on today's WST price and gamma walls.
